Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer.

Research output: Contribution to journalArticleResearchpeer-review

Fingerprint Dive into the research topics of 'Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer.'. Together they form a unique fingerprint.

Medicine & Life Sciences